GenMont Biotech Incorporation (TPE:3164)

Market Cap	1.82B
Revenue (ttm)	368.41M
Net Income (ttm)	38.96M
Shares Out	85.51M
EPS (ttm)	0.45
PE Ratio	47.21
Forward PE	n/a
Dividend	0.80 (3.77%)
Ex-Dividend Date	Mar 27, 2025

Volume	12,103
Average Volume	31,741
Open	21.30
Previous Close	21.25
Day's Range	21.25 - 21.30
52-Week Range	17.20 - 24.60
Beta	0.16
RSI	69.83
Earnings Date	Aug 8, 2025

About TPE:3164

GenMont Biotech Incorporation engages in the research, development, manufacturing and sales of various probiotic health products in Taiwan. The company offers functional probiotics raw materials. The company offers functional probiotics raw materials, capsules, powder, tablets, and liquid products. The company provides original formula design and manufacturing, and equipment manufacturing services for healthcare food, as well as cooperates in the research, production, and clinical trials of various products. GenMont Biotech Incorporation was fo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3164

Financial Performance

In 2024, TPE:3164's revenue was 385.37 million, an increase of 21.18% compared to the previous year's 318.02 million. Earnings were 57.25 million, an increase of 73.54%.